BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34061176)

  • 1. cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7.
    Li L; Lee J; Cho A; Kim JH; Ju W; An JN; Park JH; Zhu SM; Lee J; Yu SS; Lim CS; Kim DK; Kim YS; Yang SH; Lee JP
    Clin Sci (Lond); 2021 Jun; 135(11):1427-1444. PubMed ID: 34061176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosis.
    Kim YC; Lee J; An JN; Kim JH; Choi YW; Li L; Kwon SH; Lee MY; Lee B; Jeong JG; Yu SS; Lim CS; Kim YS; Kim S; Yang SH; Lee JP
    Sci Rep; 2019 Sep; 9(1):13495. PubMed ID: 31530851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cMet agonistic antibody attenuates apoptosis in ischaemia-reperfusion-induced kidney injury.
    An JN; Li L; Lee J; Yu SS; Lee J; Kim YC; Kim DK; Oh YK; Lim CS; Kim YS; Kim S; Yang SH; Lee JP
    J Cell Mol Med; 2020 May; 24(10):5640-5651. PubMed ID: 32239661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt1 is involved in renal fibrosis and tubular apoptosis in a murine model of acute kidney injury-to-chronic kidney disease transition.
    Kim IY; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
    Exp Cell Res; 2023 Mar; 424(2):113509. PubMed ID: 36773738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
    Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
    Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury.
    Chen M; Wen X; Gao Y; Liu B; Zhong C; Nie J; Liang H
    Int Immunopharmacol; 2021 Nov; 100():108142. PubMed ID: 34555644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia-reperfusion injury.
    Inotani S; Taniguchi Y; Nakamura K; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Sano S; Yanagita M; Terada Y
    Nephrol Dial Transplant; 2022 Feb; 37(3):454-468. PubMed ID: 34724064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gremlin1 and TGF-β1 protect kidney tubular epithelial cells from ischemia-reperfusion injury through different pathways.
    Gao X; Han L; Yao X; Ma L
    Int Urol Nephrol; 2022 Jun; 54(6):1311-1321. PubMed ID: 34633599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury.
    Lai CF; Lin SL; Chiang WC; Chen YM; Wu VC; Young GH; Ko WJ; Kuo ML; Tsai TJ; Wu KD
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F581-92. PubMed ID: 24920753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
    Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
    Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Akt1 in renal fibrosis and tubular dedifferentiation during the progression of acute kidney injury to chronic kidney disease.
    Kim IY; Park YK; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
    Korean J Intern Med; 2021 Jul; 36(4):962-974. PubMed ID: 33322851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
    Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
    Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury.
    Xie ZY; Dong W; Zhang L; Wang MJ; Xiao ZM; Zhang YH; Shi WX; Huang Y; Yang Y; Li CL; Fu L; Zhao XC; Li RZ; Li ZL; Chen YH; Ye ZM; Liu SX; Dong Z; Liang XL
    Acta Pharmacol Sin; 2022 Aug; 43(8):2081-2093. PubMed ID: 34937917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability.
    Wu M; Chen W; Miao M; Jin Q; Zhang S; Bai M; Fan J; Zhang Y; Zhang A; Jia Z; Huang S
    Clin Sci (Lond); 2021 Jul; 135(14):1707-1726. PubMed ID: 34255035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fibrotic signaling in a murine model for intra-arterial contrast-induced acute kidney injury.
    Sharma A; Kilari S; Cai C; Simeon ML; Misra S
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1210-F1219. PubMed ID: 32200666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
    Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
    Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure.
    Su H; Ye C; Lei CT; Tang H; Zeng JY; Yi F; Zhang C
    FASEB J; 2020 Jan; 34(1):1620-1636. PubMed ID: 31914692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Flavonoids from Leaves of Carya Cathayensis Ameliorate Renal Fibrosis via the miR-21/Smad7 Signaling Pathway.
    Wu X; Ding X; Ding Z; Jia P
    Cell Physiol Biochem; 2018; 49(4):1551-1563. PubMed ID: 30212825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent effects of AKI to CKD models on inflammation and fibrosis.
    Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.